One of the first published studies that employed Nbs for TαT involved 213Bi conjugated to an anti-PSMA (prostate-specific membrane antigen) Nb to investigate its efficacy as a potential therapeutic for prostate tumors [108]. This evidence concerns the gene FOLH1 and prostate neoplasm.